Literature DB >> 3533568

Effect of nifedipine on plasma catecholamines in man at rest and during exercise.

G Defer, Y C Guezennec, F Lhoste.   

Abstract

Blood pressure, heart rate, and plasma catecholamine concentrations were measured in 9 normotensive volunteers during a randomized cross-over study of oral nifedipine (10 mg X 5) and placebo; measurements were made at rest and during maximal anaerobic exercise. At rest nifedipine reduced blood pressure and increased heart rate and plasma noradrenaline, whereas plasma adrenaline did not change. During exercise, the blood pressure response was similar in nifedipine and placebo treated subjects; however, heart rate was significantly higher with nifedipine. Plasma noradrenaline increased more during exercise in nifedipine-treated subjects. By contrast, nifedipine inhibited the increase in plasma adrenaline induced by exercise. The results suggest that peripheral vasodilatation induced by nifedipine is responsible for increased sympathetic nerve activity, both at rest and during exercise, and that nifedipine inhibits adrenaline secretion in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533568     DOI: 10.1007/bf00608224

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

Review 1.  Catecholamines.

Authors:  J Axelrod; R Weinshilboum
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

2.  Comparison of acute effects of nifedipine in normotensive and hypertensive man.

Authors:  O Lederballe Pedersen; N J Christensen; K D Rämsch
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

3.  Decreased plasma epinephrine concentrations after glucose ingestion in humans.

Authors:  P Trunet; F Lhoste; J C Ansquer; S Kestenbaum; C Sabatier; J P Tillement; M Rapin
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

4.  Isotope derivative measurements of catecholamines in the study of human metabolic physiology and pathophysiology: a symposium.

Authors: 
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

5.  Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.

Authors:  K Hiramatsu; F Yamagishi; T Kubota; T Yamada
Journal:  Am Heart J       Date:  1982-12       Impact factor: 4.749

6.  Adrenaline secretion during exercise.

Authors:  J B Warren; N Dalton; C Turner; T J Clark; P A Toseland
Journal:  Clin Sci (Lond)       Date:  1984-01       Impact factor: 6.124

7.  Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.

Authors:  J Feely
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

8.  Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade.

Authors:  D Serfas; D M Shoback; B H Lorell
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

9.  Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.

Authors:  G Leonetti; C Cuspidi; L Sampieri; L Terzoli; A Zanchetti
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

10.  Catecholamines, growth hormone, cortisol, insulin, and sex hormones in anaerobic and aerobic exercise.

Authors:  W Kindermann; A Schnabel; W M Schmitt; G Biro; J Cassens; F Weber
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.